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Psychological stressors can lead to distress and result in autonomic arousal and activation of a stress response.
Ongoing or persistent stress can disrupt the stress response feedback mechanisms and result in elevated cortisol
and pro-inflammatory cytokines which can cause damage to brain regions involved in the regulation of mood and
emotion. We propose that the magnitude of the stress response experienced in response to psychological stressors
depends on a number of modifiable psychological processes including an individual’s level of self-compassion,
dispositional mindfulness, tendency to ruminate and attentional bias. We further propose that the stress
response elected by psychological stressors can be meditated by influencing these modifiable psychological
processes, and that meditation practices can decrease stress and improve mood by decreasing stress reactivity on a
psychological, physiological and neurobiological level. We explore this in a narrative review.1. Introduction
1.1. Psychological stressors result in psychological distress
Stressors are circumstances that threaten a goal, including mainte-
nance of physical safety (physical stressors) or psychological well-being
and include psychological stressors such as those related to work,
home and personal circumstances [1,2]. Distress is a negative psycho-
logical response to such threats and can include a variety of affective and
cognitive states, such as anxiety, sadness, frustration [1].1.2. Distress results in activation of the stress response
As stressors can be both real or perceived threats to homeostasis or
well-being, even in the absence of a physical threat, psychological
stressors and related thoughts and emotional states associated with a
sense of uncertainty or distress result in the activation of a comprehen-
sive stress response [3]. For example, Meta-Analysis shows that athletesSport, Victoria University, Melbo
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evier Ltd. This is an open access aanticipating a sporting competition commonly experience emotional and
physiological responses resulting from their expectation of psychosocial
and physical stress, which corresponds to increased cortisol levels [4].
Activation of a stress response is controlled by the autonomic nervous
system (ANS) [3], comprising of the sympathetic nervous system (SNS)
and the parasympathetic nervous system (PNS) [5]. In situations of
danger, the SNS initiates a number of physiological changes known as the
‘fight-flight-freeze’ response to maximize the chances of surviving the
threat [5]. The SNS also regulates pro-inflammatory cytokine production
by releasing the neurotransmitter norepinephrine into peripheral tissues
and organ systems, which results in the downstream up-regulation
transcription of the pro-inflammatory cytokines [6].
Once the threat is gone, the PNS, the main component of which is the
vagus nerve [7], activates the relaxation, or “rest and digest” response
and returns the body to homeostasis. The hypothalamus activates
another component of the stress response system known as the
hypothalamic-pituitary-adrenal (HPA) axis, which regulates the down-
stream release of hormones such as the glucocorticoid steroid hormone,urne, VIC, 3011, Australia.
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Table 1
Meditation Subtypes – reproduced with permission from Ref. [32]].



























































































FA¼Focused attention, OM ¼ open monitoring.
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Cortisol has many metabolic and physiological functions, one of
which is to maintain a steady supply of blood sugar, which ensures that
there is sufficient energy available to cope with ongoing or prolonged
stressors [9]. In response to stressors, cortisol is released for several
hours. At a certain blood concentration level, cortisol binds to
low-affinity glucocorticoid receptors [10]. The resulting activation of
these glucocorticoid receptors terminate the stress response and this is
thought to largely subserve HPA axis feedback regulation [11].
1.3. Persistent activation of the stress response results in HPA dysfunction
and depressive mood
This negative feedback control mechanism ensures that the secretion
of cortisol and other hormones are maintained within a relatively narrow
bandwidth [8]. However, the delicate negative feedback control mech-
anism regulating both baseline HPA function and responsiveness to stress
can be disrupted with too much exposure to stressful events, including
perceived or psychological stressors [9]. While cortisol normally exerts
an inhibitory effect of glucocorticoid activation on immune response
gene transcription, under conditions of frequent or chronic threat, HPA
axis-activation can lead to increases in inflammation as demonstrated by
increases in cytokine levels (referred to as glucocorticoid resistance, or
glucocorticoid insensitivity) [6]. This altered immune–endocrine inter-
action and increased inflammatory profile have been linked to the onset
of mental disorders, such as depression [12,13]. Meta-Analysis of seven
studies shows a blunted recovery following stressful events in individuals
with depression, as these individuals show much higher cortisol levels
following a psychologically stressful event, compared to individuals
without depression, particularly among older and more severely
depressed individuals [14]. Approximately 50% of individuals who have
depression have flattened cortisol circadian rhythm, with evening levels
being elevated [15,16].
1.4. HPA axis dysfunction is associated with damage in brain regions that
regulate mood and emotion
Importantly, acute and chronic stress and subsequent excess cortico-
steroids can damage the brain [17], particularly in areas associated with
the regulation of mood and emotion, including the hippocampus [18]
and the prefrontal cortex, both of which show atrophy [19], while neu-
rons in amygdala show growth in response to stress that corresponds with
increases in anxiety [19]. Previous research clearly shows that depression
is associated with an increased expression of pro-inflammatory cytokines
[20]. Individuals with depression have higher circulating levels of
pro-inflammatory cytokine interferon-γ (INF-γ) [21], interleukin-1β
(IL-1β) [22], tumour necrosis factor-α (TNF-α) [23], and interleukin-6
(IL-6) [24]. Treatment with the cytokine interferon-α (INF-α) [25] in-
duces depressive symptoms in humans, and symptoms are seen to reduce
with the cessation of therapy [26] and are also abrogated by antide-
pressant treatment [27]. High plasma concentrations of acute-phase
proteins and inflammatory cytokines are associated with a nonresponse
to antidepressants in individuals with depression [21]. Importantly,
pro-inflammatory cytokines induce depression-associated cellular
apoptosis [28] in the amygdala [29] by influencing intrinsic apoptosis
factors including intracellular Ca2þ, glutamate excitotoxicity and free
radicals [30]. Thus, heightened inflammatory cytokine levels driven by
stress may contribute to depression symptoms by contributing to cell
death in brain regions involved in the regulation of mood and emotion.
1.5. Meditation
Meditation is defined and characterized in a multitude of ways,
stemming from different approaches and traditions throughout history,
each with its own theoretical underpinnings and variety of techniques.
Currently, there is no agreed-upon definition of meditation in the2
scientific literature [31]. For research purposes in clinical health appli-
cations, different techniques have been classified as focused attention
(FA) or open monitoring (OM) (See Table 1) [32]. The most popular
meditative techniques lie somewhere on a continuum between concen-
trative and mindful types and generally include a component of mind-
fulness [33]. As suggested by Awasthi [34] we have adopted an
operational definition of meditation that is inclusive of traditional
ontological (i.e., metaphysical) descriptions, as well as the modern
neurocognitive account of the phenomena.1.6. Meditation meditates maladaptive distress: an integrative model
A wide body of literature shows that mediation practices are associ-
ated with improved mental health and wellbeing in diverse popuations
[35–37]. We propose that meditation practices reduce the distress
experienced resulting from psychological stressors by impacting a num-
ber of key psychological processes. By impacting these psychological
process, the relationship with the stressor is altered and the associated
distress is reduced. This reduction, we propose, is associated with less
autonomic arousal and activation of the stress response, as well as less
acute activation in brain regions associated with rumination in the longer
term, less stress derived damage to brain regions important in the regu-
lation of mood of emotion, as depicted in Fig. 1. This article adds to the
existing literature as it is the first, to our knowledge, to explore the
impact of mindfulness on psychological, physiological and neurobio-
logical outcomes concurrently from the perspective of stress regulation
and the impacts of this on mood, particularly depression. Studying
Fig. 1. Impacts of meditation on stress related psychological, physiological and neurobiological outcomes
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may promote mood and/or be an effective treatment of mental ill-health
as well as provide a greater understanding into what populations it might
be most beneficial to. In order to explore this, we aimed to narratively
review meta-analytic and systematic review studies of meditation with a
focus on psychological, physiological and neurobiological impacts.
2. Methods
We aimed to narratively review meta-analytic and systematic review
studies of all forms of meditation with a focus on psychological and/or
biological mechanisms linking meditation practice with mood, with a
particular focus on those mechanisms involved in the stress response.
This includes studies of: (1) psychological processes (self-compassion,
dispositional mindfulness, rumination, exposure, meta-cognition, atten-
tion, (2) physiological processes (the autonomic nervous system - heart
rate, blood pressure, cytokines, and cortisol) and, (3) neurobiological
processes (brain structure and function).
A single author conducted a search of the literature using a number of
databases (PubMed, Web of Science, Scopus) as well as Google Scholar
and a panel of expert also contributed to the literature search. The cut-off
point for the literature search was June 2020. Meta-Analysis and sys-
tematic reviews were eligible for inclusion. Search terms included but
were not limited to: “mindful*,” “meditate*”,” “psych*” “neuro*” “stress”
“autonomic” “mental illness” “mental health” “cytokine” “endocrine.”
Searches only included studies published in English. Systemtic reviews
and meta-analyses were included if they examined the impact of a
meditation practice on physiological, psychological or neurobiological
outcomes in any population. Quality assessment of included studies was
not conducted and thus all eligible articles were included. Data were
coded according to the specific outcome explored (psychological pro-
cesses, physiological processes, neurobiological processes).
3. Results
In total, we included 24 Meta-Analysis and/or systematic review
studies assessing the impact of meditation psychological processes, the
autonomic nervous system and neurobiological processes. These studies3
and a brief summary of their findings are presented in Table 2 and dis-
cussed in more detail in the text.
3.1. Meditation decreases distress experienced resulting from psychological
stressors by influencing psychological processes
3.1.1. Mindfulness
Mindfulness is defined as the awareness that arises from paying
attention to the present moment, non-judgmentally [60]. In their
Meta-Analysis of 22 RCT’s, Galante and colleagues found that
kindness-based meditation increased mindfulness compared to a
no-intervention control group [38]. In their systematic review, Gu et al.
also reported that in 12 RCTs and 4 quasi-experimental studies of OM
meditations (MBSR and MBCT), mindfulness mediated symptoms of
depression (n ¼ 9), self-reported stress (n ¼ 3), anxiety symptoms (n ¼
3), mood states (n ¼ 3), quality of life (n ¼ 1), and anger expression (n ¼
1) in diverse samples of individuals, including individuals with depres-
sive disorders, and non-clinical samples of individuals [39]. The authors
noted that evidence for mindfulness as a mediator of the impact of
meditation on psychological outcomes was considered to be moderate
[61]. In a Systematic Review of RCTs, pre-post studies, cross-sectional
studies, cohort studies and qualitative studies, various
meditation-based interventions increased mindfulness levels and
improved burnout, depression, anxiety, and stress in health care pro-
fessionals [40].
Mindfulness has been shown to reduce psychological distress [62].
Mindfulness training enhances self-regulation of emotion and behaviours
[63] due to greater acceptance and self-awareness of unpleasant emo-
tions and distress, rather than impulsive reaction, rumination or avoid-
ance of these [64]. This enhanced acceptance of experiences is thought to
lead to increased distress tolerance [65].
3.1.2. Self-compassion
Self-compassion is the act of extending compassion to one’s self in
instances of perceived inadequacy, failure, or general suffering [66], not
avoiding or disconnecting from it, and offering nonjudgmental under-
standing to one’s pain, inadequacies and failures [67].
In their Meta-Analysis of 22 RCT’s, Galante and colleagues found that
Table 2
Studies included in the narrative review and a summary of their findings on
psychological processes, autonomic and neurobiological processes assessed.
Outcome assessed Author Findings Study type




[39] OM meditation increased
mindfulness and mediated
impacts of meditation on
psychological outcomes
SR & MA
Self-compassion [40] Various meditation forms
increased mindfulness
SR




[41] OM studies increased self-
compassion
SR & MA





Rumination [39] OM meditation decreased
rumination and mediated
impacts of meditation on
psychological outcomes
SR & MA
[42] OM/FA meditation-based study
reduced rumination compared
to treatment as usual and a
waitlist control, but not
compared to an active control
group
SR & MA
Attention [43] Various meditation forms
enhanced executive control
SR
[44] Pure mindfulness meditation




[45] Programs that included FA and
OM produced a significant effect
on overall cognition
SR & MA
[46] FA and OM had a medium effect
on attention
SR & MA
Blood pressure [47] TM (oriented focused attention)
lowered SBP and DBP
Review of
SR & MAs
[88] FA meditation decreased SBP,
OM meditation did not. No
change in DBP
SR & MA





ambulatory SBP and DBP
SR & MA
Heart rate [88] OM meditation decreased HR,
FA did not
SR & MA
HRV [49] Varied meditation forms
analysed together did not
influence HRV
SR & MA
[88] OM and oriented FA meditation
interventions did not influence
HRV
SR & MA
[50] OM meditation interventions
did not influence HRV
SR & MA
Inflammatory proteins [51] OM reduced CRP and found a
lack of replicated effects for IL-
1, IL-6, IL-8, IL-10
SR & MA
[88] OM did not decrease CRP, IL-6.
TNF-a decreased following
combined analysis of various
meditation forms
SR & MA
[50] OM did not decrease IL-6 or CRP SR & MA
[52] OM did not influence IL-6, IL-8,
TNF-α, IFN-γ, IL-10
SR
Cortisol [53] Varied meditation forms
(mostly FA) analysed together
SR & MA
Table 2 (continued )
Outcome assessed Author Findings Study type
reduced blood and salivary
cortisol
[54] OM meditation interventions




[88] Buddhist walking and
Integrated Amrita Meditation
decreased blood cortisol. FA
meditation did not decrease
blood cortisol
SR & MA










[57] Cortical thickening seen in
BA10 of long-term meditators,
irrespective of the meditation
type. Various meditation forms
associated with greater white






[124] FA and OM associated with




[58] MM meditations activate the










[57] Various meditation forms
associated with structural
declines in posterior cingulate
cortex
SR & MA
[124] FA meditation associated with
deactivation in BA 30, loving-
kindness/compassion
meditation associated with
activation in BA 23/31
SR & MA
Inferior parietal lobule [124] FA meditation associated with











[58] Vipassana meditation resulted
in a thicker right hippocampus
SR
The insular cortex [57] Various meditation forms
associated with structural





[124] FA, OM associated with
activation in BA13. Mantra
recitation (FA) associated with
deactivation in BA13
SR & MA




BA¼Brodmanns area, CRP¼C reactive protein, FA¼Focused attention, DBP ¼
Diastolic blood pressure, HR¼Heart rate, HRV¼Heart rate variability, IL-1 ¼
Interleukin-1, IL-6 ¼ Interleukin-6, IL-8 ¼ Interleukin-8, IL-10 ¼ ¼ Interleukin-
10, IFN-γ ¼ interferon-gamma, IL-10 OM¼Open monitoring, MA ¼ Meta-anal-
ysis, MBSR¼Mindfulness based stress reduction, MM¼Mindfulness meditation,
SBP¼Systolic blood pressure, SR¼Systemtic review, TM ¼ Transcendental
meditation, TNF-α ¼ Tumour necrosis factor-alpha.
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intervention control group [38]. These findings are consistent with the
systematic review from Gu et al., which reported that in 2 RCTs and 1
quasi-experimental study, OM meditation-based studies (MBSR and
MBCT) increased self-compassion andmediate its effects on symptoms on
psychological outcomes, however, the authors noted that the level of
evidence for self-compassion as a mediator was preliminary but incon-
sistent [39]. A Meta-Analysis of studies showed that self-compassion is a
robust predictor of psychological health [68]. In a Systematic Review of
RCTs, pre-post studies, cross-sectional studies, cohort studies and quali-
tative studies, various meditation-based interventions increased
self-compassion levels and improved burnout, depression, anxiety, and
stress in health care professionals [40]. In a Meta-Analysis of 22 OM
studies (MBSR- or MBCT-based), comprising university students and
community-dwelling individuals, a significant medium effect size in-
crease in self-compassion was found compared to control conditions
[41].
The psychological skills developed through meditation practices,
such as self-compassion [69] have been associated with less self-reported
stress, indicating that these skills change the relationships that in-
dividuals have, and reactivity to, psychological stressors. For example, in
young people with elevated symptoms of depression, high
self-compassion has been found to buffer against the experience of anx-
iety following a public speaking exercise, which is a psychological
stressor [70]. Some authors have hypothesised that high levels of
self-compassion may improve psychological health by decreasing
avoidance and rumination as individuals with high self-compassion are
less likely to avoid distressing thoughts and emotions associated with
psychological stressors [71]. For example, individuals with depression
self-report having less self-compassion compared to individuals who
have never experienced depression [66]. This is supported by data
showing that higher levels of self-compassion are associated with lower
symptoms of depression, stress, increased quality of life, happiness,
optimism, positive affect, wisdom, personal initiative, curiosity and
exploration, agreeableness, extroversion, and conscientiousness [69].
3.1.3. Rumination
Rumination is the process of repetitively thinking about the causes,
consequences, and symptoms of negative affect and it contributes to
emotional distress [72].
In their systematic review Gu et al., report that in 5 RCTs and 3 quasi-
experimental studies of OM meditation (MBSR and MBCT), that repeti-
tive negative thinking, which included both rumination and worry, was
found to mediate symptoms of depression (n ¼ 5), followed by stress (n
¼ 2), anxiety (n ¼ 1) and global psychopathological symptoms (n ¼ 1),
mostly in individuals experiencing symptoms of depression and cancer
survivors and patients, and that the level of evidence for this finding was
moderate [39]. In a Meta-Analysis OM/FA meditation-based in-
terventions (10 MBCT studies and one mindfulness yoga study), the
intervention was associated with a moderate reduction in ruminative
thoughts compared to treatment as usual or a waitlist control, however,
no effect of the mindfulness-based intervention was seen when
comparing the three OM/FA interventions with other active treatments
[42].
Meditation practices have been hypothesised to decrease rumination
through their ability to train and cultivate moment-to-moment awareness
[73]. Duringmeditation, attention is deliberately shifted from potentially
ruminative thoughts to the immediate here-and-now experience, and
individuals de-centre from their thoughts, or exercise meta-cognition as
discussed below, which enables nonjudgmental acceptance of transient
thoughts rather than a rumination on psychological stressors and can
therefore decrease the distress associated with this rumination [74].
Current models of depression hypothesize that high avoidance of aver-
sive stimuli contributes to the onset and maintenance of depression
disorders [75]. Rumination has also been shown to mediate the negative
correlation between self-compassion and symptoms of depression and5
anxiety amongst undergraduate students [76]. This suggests that the
impact of self-compassion on unproductive repetitive thinking may be
one way via which it buffers against depression [76].
3.1.4. Exposure
Exposure is another process that several authors have suggested may
occur during mindfulness practice [77]. Prolonged observation of current
thoughts and emotions, without trying to avoid or escape them, can be
seen as an example of imaginal exposure, which should encourage the
extinction of fear responses and avoidance behaviors previously elicited
by these stimuli [78,79]. We were unable to locate any systematic re-
views or Meta-Analysis assessing the impact of meditation on exposure,
however consistent with this theory is pre-post data, showing that
participation in the MBSR program, which includes mindfulness medi-
tation, is associated with increases in exposure, which corresponded with
decreasing depression and anxiety symptoms and stress in adults with
chronic pain, anxiety, personal, illness- and employment-related stress
[80].
This may occur because individuals with higher self-compassion are
less likely to ruminate on distressing thoughts, to self-criticise, to avoid
distressing thoughts. Indeed, previous work involving individuals with
depression shows that rumination and avoidance mediate the relation-
ship between self-compassion and depressive symptoms, suggesting that
less self-compassionate people tend to function in a more avoiding
manner [66]. This is supported by earlier findings showing that increases
in self-compassion mediate the effect of MBSR on decreasing worry and
fear of emotion, after controlling for changes in mindfulness [81]. In-
terventions that lessen experiential avoidance produce measurable re-
ductions in fear-based pathology [82]. The work of Ford and colleagues
shows that the act of avoiding thoughts and emotions can result in psy-
chological stress [83]. In a series of studies involving university students
and community-dwelling individuals, including a longitudinal study,
Ford et al. reported that individuals who accepted their mental experi-
ences experienced fewer negative emotional responses to stress, both
within a laboratory setting and in daily life [83]. These authors high-
lighted that negative emotions and thoughts are common and that some
people tend to accept their emotions and thoughts, while others tend to
judge them as inappropriate or bad. Authors propose that the act of
accepting or judging emotions or thoughts can impact longer-term psy-
chological outcomes [83].
3.1.5. Metacognition
Metacognitive awareness is the ability to decenter from thoughts and
emotions, and view them as passing mental events rather than identify
with them or believe thoughts to be accurate representations of reality
[84]. High levels of metacognition appear to protect against depression
relapse [85]. High metacognitive awareness has been hypothesised to
lead to reductions in rumination [84]. We could not identify any
Meta-Analysis or systemic reviews assessing the impact of meditation on
meta-cognition, however, one RCT’s showed that, in patients in remis-
sion or recovery from major depression, the mindfulness program, MBSR
increased metacognition [86].
3.1.6. Attention
Meditation practices appear to benefit attention capacity, though the
mechanisms are unclear. Comprehensive meta-analyses of FA and OM
based meditation studies in diverse populations reveal medium positive
effects across a range of attentional measures (concentration/attention,
sustained attention, orienting, alerting, conflict monitoring, executive
processing, behavioural inhibition) [46]. Some attention-training pro-
grams even appear to bolster the amygdala-prefrontal connectivity that is
important for emotional regulation and downregulation of survival re-
sponses [87].
A Meta-Analysis of 39 various mindfulness meditation programs
delivered to non-clinical populations of adults shows that pure mind-
fulness meditation interventions appear to be more effective at impacting
M.C. Pascoe et al. Comprehensive Psychoneuroendocrinology 6 (2021) 100037attention than comprehensive MBSR programs that incorporate medita-
tion among other strategies [44]. In a MA or RCTs in adults, cognitive
processes underpinned by attention, such as working memory and
inhibitory control, appear to benefit from a combination of MBSR and
other mindfulness-based training programs [43]. AMeta-Analysis of both
FA and OM based studies in healthy adults showed that programs that
included FA and OM elements produced a significant but small effect on
overall cognition, but no significant effect was found for FA and there
was not a sufficient number of OM studies to conduct Meta-Analysis. The
authors concluded that even single-session mindfulness inductions that
direct attentional awareness confers short-term benefits to higher-order
capacities, such as decision-making [45]. Increased operational and
methodological consistency across studies is needed to better understand
how meditation improves attention.
3.2. Meditation decreases autonomic arousal
We propose that meditation influences both psychological processes
that decrease distress experienced in relation to stressors, and the cor-
responding autonomic arousal generally produced in response to
stressors. These include increases in heart rate, respiration and blood
pressure, and the release of blood sugar (glucose) into the bloodstream,
[8]. This is explored below.
3.2.1. Blood pressure
There is strong evidence for the beneficial effects of meditation on
blood pressure (BP), as shown from multiple Meta-Analyses of rando-
mised controlled trials (RCTs). One Meta-Analysis shows that concen-
trative or focused attention forms of meditation decreased resting SBP by
5.55 mm of mercury (mmHg) at post-intervention, in 3 studies
comprising of 72 individuals. Transcendental Meditation (TM) was
similarly seen to significantly decrease resting systolic blood pressure
(SBP) at post intervention by 8.97 mmHg, compared to the time/atten-
tion control group, in 3 studies comprising of 151 individuals. Open
monitoring meditations, however, were not seen to decrease resting SBP
at post-intervention, in 5 studies comprising of 359 individuals, from
diverse populations [88]. Additionally, none of the meditation subtypes
was found to decrease resting diastolic BP at post-intervention [88].
However, a limitation is that many of the included studies did not include
a follow-up period. Therefore the longevity of the observed effects is
unknown.
This is consistent with findings from a review of eight systematic
reviews and meta-analyses showing a clear trend of TM in lowering SBP
by ~4 mm Hg and DBP by ~2 mm Hg, which is comparable with other
lifestyle interventions such as weight loss, diet, and exercise [47].
Another recent Meta-Analysis of RCTs showed that TM reduced ambu-
latory SBP by 2.49 mmHg and DBP by 4.26 mmHg. This was smaller than
the decrease seen following a combined analysis of contemplative
meditation forms (n ¼ 7 studies) which reduced ambulatory SBP by
3.77 mmHg but DBP by 2.18 mmHg [48].
3.2.2. Heart rate
In a Meta-Analysis of 5 RCTs comprising of 140 individuals from
diverse populations, OM meditation decreased resting heart rate by 3.11
beats per minute (bpm) at post-intervention, compared to a time/atten-
tion control group [88]. This is slightly smaller than the effects of aerobic
exercise, which has been reported to reduce resting heart rate by 5 bpm
in Meta-Analysis [89]. Focused attentions forms of meditation however
were not seen to significantly decrease resting HR at post-intervention, in
three RCTs comprising 72 individuals [88]. It appears that there may be
differences between meditation subtypes in terms of autonomic regula-
tion and perhaps stress reactivity, however, the longevity of the observed
effects is unknown as few studies have assessed the long term impacts of
meditation on heart rate.6
3.2.3. Meditation and heart rate variability
Heart rate variability (HRV) is the variation in the time interval be-
tween heart beats. HRV reflects the flexibility of the cardiovascular sys-
tem to cope with physical/psychological challenges and is measured by
the variation in the beat-to-beat interval [90]. Higher HRV is associated
with better emotional regulation [90].
A previous Meta-Analysis identifies only two RCTs assessing the
impact of OMmeditation on HRV, and only one RCT assessing the impact
of self-transcending meditation (can be considered FA as mantra based
according to Table 1) on HRV. These few studies show that meditation
does not influence HRV compared to a time/attention control group [88].
This is consistent with the findings of a more recent Meta-Analysis
including nineteen Mindfulness-Based Interventions (MBIs) RCTs
(including MBSR), which found that MBIs were not efficacious in
increasing vagally-mediated resting-state HRV relative to control condi-
tions [49], however, this Meta-Analysis combined different types of MBIs
in the analysis including loving-kindness meditation, mindful awareness
in body-oriented therapy, mindful awareness practices and MBSR, and
TM among others, so the impact of different meditation types on HRV is
still unknown. Finally, in a Meta-Analysis of two RCTs and one pilot
assessing MBSR (OM, object orientation) pooled estimates did not reach
statistical significance [50]. However, these authors noted that the
scarcity of studies assessing the effects of the standardized MBIs on HRV
is a limitation, demonstrating that further research is required to un-
derstand the possible impact, if any, of meditation on HRV.
3.2.4. Inflammatory proteins
Inflammatory proteins are produced by immune cells and serve as
extracellular communicators during immune system activity and can
promote inflammation. Cytokines are small cell signalling protein mol-
ecules that mediate and regulate immunity and inflammation [20].
Limited evidence suggests that meditation may influence cytokine
levels. In a Meta-Analysis comparing the impact of meditation and a
time/attention control group, five RCTs comprising of 298 participants,
found that OM forms of meditation resulted in a small effect size decrease
c-reactive protein (CRP), the production of which is induced by pro-
inflammatory cytokines [91]. However, the difference was not statisti-
cally significant [88]. Similarly, in four RCTs comprising 98 participants,
IL-6 was not seen to change following OM meditation [88]. There was
however significant variation between these four studies with regards to
the type of time/attention control intervention delivered and the inter-
vention duration. Furthermore, two of the studies included in the anal-
ysis measured CRP and IL-6 levels at 2 and 10 months post intervention,
while the remaining two studies assessed CRP and IL-6 levels directly at
post intervention [88], indicating that significant variability exists in the
methodology used to assess the impact of meditation on inflammation.
In three RCTs comprising 100 participants, in a combined analysis of
two MBSR interventions and one meditation retreat, TNF-α was found to
decrease by 0.21 pg/mL following the meditation program. However,
when the two MBSR interventions were assessed alone, there was no
difference between meditation and the time attention/control group
[88]. These findings are consistent with a recent Meta-Analysis of four
RCTs assessing mindfulness-based interventions (OM, object orientation)
which showed no impact of meditation on IL-6 or CRP [50]. In a Sys-
tematic Review of RCTs, non-RCTs, and open trials with a pre-post
analysis and delivered to healthy populations and cancer patients, com-
bined analysis of MBSR, MBCT, mindfulness meditation, mindfulness
training and mindful awareness practices, (can be considered predomi-
nantly OM object-orientation) had no effect on cytokines (IL-6 measured
in three studies, IL-8 in two studies, TNF-α in two studies, and IFN-γ and
IL-10 in one study) but were found to increase the levels of the neuro-
peptide insulin-like growth factor 1 [52]. Contrary to the above findings,
a Meta-Analysis of RCTs using OM meditation interventions (predomi-
nantly MBSR) found that OM reduced CRP but there were no effects for
IL-1, IL-6, IL-8, IL-10 [51].
The above-reported Meta-Analysis highlight that few well-controlled
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nificant variably is present in methodology in existing studies. Therefore,
it would be valuable for future trials to further explore the impact of
meditation on CRP, IL-6 and TNF-α, to explore if these effects are
dependent upon the delivery format, duration, and dosage of the medi-
tation practice.
Many studies indicate that various stressors, including psychological
stressors alone, can induce pro-inflammatory (interleukin-1 [IL-1],
interleukin-6 [IL-6]) and tumour necrosis factor-alpha [TNF-α] cyto-
kine secretion [92–94]. A bi-directional feedback loop between cytokines
and cortisol is hypothesised to be central to the appropriate functioning
of the HPA axis while maintaining homeostasis of the immune system
[95]. For example, the stress-induced release of certain inflammatory
cytokines such as IL-6, TNF-α, and interleukin (IL-10), activate the HPA
axis and cause the release of cortisol [95,96]. The increased cortisol
induced negative-feedback then suppress the further release of cytokines
[95,97,98]. However, glucocorticoid receptor abnormalities resulting
from excessive cortisol can reduce the immune system’s capacity to
respond to cortisol and subsequently lower inflammation. This results in
concurrently sustained levels of cortisol and cytokine release [97,98].
3.2.5. Cortisol
In individuals considered at risk for elevated cortisol levels, such as
due to illness or disease, Meta-Analysis showed various meditation in-
terventions, but mostly FA based, decreased blood cortisol in individuals
with a somatic illness. However, salivary cortisol was only seen to
decrease in the sub-set of individuals living in stressful life situations
[53]. In a Systematic Review of six OM meditation-based intervention
studies, significant reductions in salivary cortisol levels were observed
among within-participants studies but not in randomised controlled trial
designs comprising of diverse populations [54]. In a Meta-Analysis of
four MBSR and one MBCT RCTs, cortisol was seen to decrease in healthy
adults following the meditation-based intervention, with no difference
between active and passive control groups in diverse populations [56].
Intervention duration had a significant effect; interventions longer than
1200 min seem to be most effective at reducing cortisol levels, and the
meditation was effective for men compared to women [56].
This is consistent with our previous Meta-Analysis work comparing
the impact of meditation and a time/attention control group, that shows
from two studies of Buddhist walking meditation and one study of In-
tegrated Amrita Meditation, that meditation decreased blood cortisol,
(comprising 102 individuals from diverse populations). This Meta-
Analysis also showed that autonomic self-transcending forms of medi-
tation, which can be considered an object-oriented focused attention
meditation form, did not decrease blood cortisol levels, in three RCTs
comprising 72 individuals [88]. This is consistent with our earlier sys-
tematic review showing that different forms of meditation appear to
impact cortisol levels to a differing degree [55]. This systematic review
included RCTs of interventions that included meditation practice and
measured cortisol in conjunction with a measure of anxious sympto-
mology and showed that mindfulness meditation, MBSR, and MBCT, and
to a lesser degree Integrative-Mind-Body-Training and mindful breath-
ing/diaphragmatic exercises, are all associated with decreases in cortisol
levels, indicating that both OM and FA forms of meditation reduce
cortisol levels (see Table 1). The findings from this systematic review also
preliminarily indicated that meditation practices comprising of more
hours of meditation practice per week may be more effective than those
with fewer hours, in terms of regulating the autonomic nervous system
and stress response, for example, mindfulness bases stress reduction was
seen to decrease salivary cortisol when practiced by healthy adults for at
least 2.5 h a week for eight weeks, and when participants were encour-
aged to practice at home for at least a further 315min/week [99], but not
to decrease salivary cortisol levels when practiced for 50 min/week over
12 weeks in healthy school children [100]. However, the impact of
medication practices on cortisol levels likely varies depending on the
particular population studied and the particular meditation practice, and7
the precise duration and frequency of meditation practice required to
elicit such changes is still unknown. Furthermore, a focus on breathing
was found to be a key component in each of the reviewed meditation
interventions that was associated with biological changes including de-
creases in cortisol levels, such as paying attention to the sensation of
breath moving through the nostrils and the rise and fall of the abdomen
in mindfulness meditation, or focusing on breathing slowly via contrac-
tion of the pharynx in integrative-Mind-Body-Training, compared to
some of the other forms of meditation studied, which instead focused
largely on mantra, visualisations, or muscle relaxation, and were less
frequently found to influence the autonomic outcomes studied. Indeed,
breathing is one of the actions of the ANS that individuals can control,
and activation of the PNS and homeostatic state is characterized by calm,
relaxed breathing [101].
3.3. Meditation and changes in brain structure and function related to
mood
Repeatedly high levels of cortisol resulting from persistent or
repeated activation of the stress response can result in glucocorticoid
receptor resistance, by impairing the function of glucocorticoid receptors
[102]. This occurs in brain regions such as the prefrontal cortex (as well
as the paraventricular nucleus) and hippocampus [103] which disrupts
the glucocorticoid feedback control of the HPA axis [104,105]. Accord-
ingly, baseline glucocorticoid release is also seen to increase following
recurrent or persistent stress [106]. There is also evidence that high
ongoing amounts of cortisol lead to damage and remodeling in the hip-
pocampus and prefrontal cortex, as well as the amygdala [107]. The
prefrontal cortex is important for executive function, working memory
and self-regulatory behaviours [108], while the hippocampus is involved
in the regulation of mood [107] and the amygdala is involved in the
regulation of emotional and behavioural responses [109]. Changes in the
structure and function of these regions are observed in individuals with
mood disorders such as depression [107], and illustrates, at least in part,
why persistent activation of amygdala-prefrontal survival responses is
associated with the onset of a number of psychiatric disorders such as
depression [110,111], which are charactered by an increase inflamma-
tory state [12].
On the other hand, meditation practices have been shown to be
associated with functional and structural changes in brain regions that
are involved in the modifiable psychological process discussed above.
The default mode network (DMN) for example is involved in emotional
regulation and hypothesised to be important in terms of the impact of
meditation on mood [112]. Alterations in DMN activity have been
associated with a number of mental disorders, including depression
[113]. For example, a number of studies have found an increase in DMN
resting-state connectivity in individuals with depression, and that this is
associated with higher levels of maladaptive rumination, indicating that
increased levels of DMN activity underlie dysfunctional emotional pro-
cessing in depression [114]. These are discussed below.
3.3.1. Default mode network
The DMN is a large-scale network of interacting brain regions that are
highly correlated with each other and appear relatively distinct from
other brain networks. This brain network shows higher activity during
the resting state, compared to when performing tasks, in a specific
constellation of brain regions, including the posterior cingulate cortex
and adjacent precuneus, medial prefrontal cortex, medial and inferior
temporal lobes, and inferior parietal lobe [113,115]. The default mode
network is most commonly shown to be active when the brain is at
wakeful rest, such as during daydreaming and mind-wandering [115].
Rumination is specifically correlated with the DMN core regions and the
dorsal medial prefrontal cortex subsystem [116].
As previously reviewed, there is compelling evidence that mindful-
ness practices reduce DMN activity [117]. The DMN is shown to be
deactivated during goal-directed tasks [113,115] and accordingly,
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in the DMN [117–119]. This may be becausemeditation practices require
metacognition and attentional focus as individuals observe their
thoughts, bring attention back to the present moment as well as focus
attention on a particular point, such as breath, a mantra, or sensory
experience. Attention and cognitively demanding activities such as
meditation, activate the task-positive brain network (TPN) [120], which
include the dorsal and ventral frontoparietal attentional networks [121]
and previous work shows activation of the TPN during task execution
suppresses DMN activity [122]. Indeed, in healthy individuals, DMN
activity correlates negatively with the goal-oriented TPN [123].
This paper will now further explore the role of mindfulness practices
on the three major subdivisions of the DMN: the ventral medial prefrontal
cortex; the dorsal medial prefrontal cortex; and the posterior cingulate
cortex and adjacent precuneus plus the lateral parietal cortex (approxi-
mately Brodmann area 39).
3.3.2. Medial prefrontal cortex; dorsal medial prefrontal cortex
In their two meta-analyses, Fox and colleagues found the various
meditation practices are associated with both changes in brain
morphology/structural changes and functional changes in the medial
prefrontal cortex [57,124]. Open monitoring and
loving-kindness/compassion meditation (a relation orientation focused
attention form of meditation, see Table 1) are associated with activation
in the rostrolateral prefrontal cortex (BA10), which extend into the
dorsolateral prefrontal cortex (BA9) for loving-kindness/compassion
meditation [124]. Increased cortical thickness is seen in the rostro-
lateral prefrontal cortex (BA10) of long-term meditators, irrespective of
the meditation type practiced, indicating that morphological changes in
rostrolateral prefrontal cortex may be generalizable beyond any partic-
ular meditative practice [57]. Focused attention meditation and OM
meditation are associated with activation in the anterior/midcingulate
cortex (BA 24 and 32 respectively), both of which are part of the medial
prefrontal cortex [125]. Fox and colleagues also reported dependable
morphological difference in the anterior/midcingulate cortex following
different meditation subtypes, specifically, in two studies, greater white
matter fibre density and/or coherence were found by means of fractional
anisotropy both in novice and long term meditators, and in a third study
increased cortical thickness was seen in long term meditators [57].
The right orbitofrontal cortex (OFC), which is sometimes referred to
as ventromedial prefrontal cortex (vmPFC), is involved in the regulation
of negative emotion and self-monitoring [126]. Specifically, it is involved
in down-regulating and reappraising negative emotional states [127]. It
is also hypothesised that meditative training may lead to greater reliance
on the OFC to guide behavior, instead of relying on static
stimulus-reward associations from the past [57,128]. Fox et al. found a
sizable (240 mm3) meta-analytic clusters of morphological difference in
the OFC [57].
These findings are consistent with those of an earlier Systematic Re-
view reporting that mindfulness meditation practice (can be considered
OM) activate the prefrontal cortex and the anterior cingulate cortex [58]
as well as a more recent Systematic Review by Magalhaes et al., which
showed greater prefrontal/frontal activity associated with various
meditation forms [59].
The results of the previous systematic review indicate that these
structural changes indicate that mindfulness can lead to heightened self-
monitoring, as well as a better ability to regulate negative emotion [58,
86]. The ability to regulate negative emotion may contribute to the
decrease in stress resulting from distressing thoughts and emotions.
3.3.3. Posterior cingulate cortex/retrosplenial cortex
The posterior cingulate cortex (PCC)/retrosplenial cortex (RSP) is a
core region in the DMN. It may serve as the main “hub” of the DMN [125]
and is associated with episodic memory retrieval [129]. In their
Meta-Analysis, Fox and colleagues found the various meditation practices
are associated with both structural and functional changes in the8
posterior cingulate cortex/retrosplenial cortex. Focused attention medi-
tation is associated with deactivation in the posterior cingulate cortex
(BA 30), while loving-kindness/compassion meditation was associated
with activation near the parieto-occipital sulcus (BA 23/31) [124]. In
their earlier Meta-Analysis, Fox et al. report structural differences in the
posterior cingulate cortex of meditators vs non-meditators, which they
interpreted as structural declines or decreases in meditation practi-
tioners, perhaps indicating a weakening of default mode network func-
tion [57]. Given that DMN activity is linked to mind wandering and
spontaneous thought [130], decreased activation in the PCC/RSP may
indicate a blunting of DMN activity perhaps reflecting reduced mind
wandering in meditators, as indicated by previous work comparing
long-term meditators with non-meditators [131].
3.3.4. Inferior parietal lobule
In their meta-analyses, Fox and colleagues found that focused atten-
tion meditation is associated with deactivation in the inferior parietal
lobule (IPL) (BA 39) while loving-kindness/compassion meditation is
associated with activations in the left inferior parietal lobule (BA 2/40)
[124], suggesting decreased processing of external sensory inputs [124].
Along with the PCC, the IPL is involved in mind-wandering [132],
episodic memory retrieval, and the simulation of future events [125]. Fox
and colleagues speculated that deactivations in the IPL might indicate
that focused attention meditation can decrease spontaneous thoughts
about past and future events as well as reflecting on the meaning and
implications of suggested events [124], which may influence the expe-
rience of distress by decreasing the frequency of worrying thoughts about
the future and increase dispositional mindfulness. Previous research
states the IPL is one brain region altered with extended daily focused
attention to moment-to-moment experience and therefore may represent
the neural underpinnings of self-reference in the psychological present
[133,134]. The IPL has been associated with experiences stepping
outside of themselves, affording a detached, or meta-cognitive perspec-
tive [135].
3.3.5. Hippocampal formation
In their Meta-Analysis, Fox and colleagues found structural brain
differences in the hippocampus in meditators compared to non-
meditators, including increases in gray matter concentration and gray
matter volume [57]. In their systematic review, Chiesa and Serretti
concluded that Vipassana meditation (FA object orientation, see Table 1)
resulted in a thicker right hippocampus, based on the work of Holzel
et al., which compared the regional gray matter concentration of medi-
tators and non-meditators [58].
The hippocampus contributes to the regulation of emotion [136]
including emotional reactions and social emotions [137]. Several mental
disorders such as major depression [138] and PTSD [139] are associated
with decreased density or volume of the hippocampus [140]. The hip-
pocampus however is the region where remodeling of synapses and the
generation new neurons have been observed [141]. Volume loss in this
region seems to be reversible [142]. Indeed, treatment with selective
serotonin reuptake inhibitors (SSRIs) has been found to lead to an in-
crease in hippocampal volume [143]. It has been suggested that some of
the behavioural effects of antidepressant treatment might depend on
neurogenesis in the hippocampus [144]. Some authors have suggested
that structural changes in the hippocampus area following mindfulness
practice may reflect improved function in regulating emotional
responding [57,145] and that structural hippocampal increases relate to
meditation’s potential amelioration of clinical conditions such as
depression [58].
3.3.6. The insular cortex
The insular cortex is the only brain region that Fox and colleagues
found to be consistently recruited or activated irrespective of the medi-
tation form, with small/non-significant activations from focused atten-
tion in BA13, and deactivation from mantra recitation, and larger
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tions [146]. With regards to structural differences, in their
Meta-Analysis, Fox et al. [57] propose that the various structural differ-
ences they found in the insular cortex (cortical thickness, cortical gyr-
ification, gray matter concentration) are tied to body-centred
meditations. This is because the studies that reported insula differences
involved explicit focus on the body, including paying attention to body
posture, respiration, temperature, and other sensations. These findings
support those reported by Treves et al., in their Meta-Analysis which
showed that mindfulness meditation practice was associated with greater
body awareness accuracy, as measured by visceral, somatosensory and
proprioceptive signals in seven RCTs [147]. Finally, these findings are
consistent with those reported in a Systematic Review by Magalhaes
et al., which reported increased insular activity in meditators [59].
The insula cortex has many functions, including involvement in
empathy [148], metacognition [149], and interoception, which is the
awareness and monitoring of internal bodily states, including respiration
or heart rate [150]. Given that many forms of meditation involve some
degree of monitoring of the body and basic metacognitive monitoring, it
is understandable that many meditation forms are associated with acti-
vation of the insular cortex.
Dysfunction of interoception is increasingly recognized as an impor-
tant component of a number of different mental disorders, and
dysfunction of the insular cortex has been shown to be involved in a
range of mental illnesses, including mood disorders [151,152]. Many
mental disorders are associated with altered attention to the body or
bodily sensations. For example, in major depressive disorder, a large
body of evidence shows that individuals have altered interoception and
decreased activity in the insula cortex [151,152]. Therefore, it has been
hypothesised that greater activity in the insular cortex may play a role in
the emotional and clinical benefits associated with meditation practices
[57,146].
3.4. The importance of individual differances
One outstanding question relates to the impact of individual differ-
ances on the efficacy of the variety of meditation practices for mood. For
example, some breathing techniques may be uncomfortable or even
distressing for some individuals [153]. Therefore it might be more
beneficial to focus attention on another sensory domain, such as sound or
repeating a mantra. Indeed, previous work has shown that HRV varies
significantly between participants in response to a single exposure to a)
classical music b) white noise c) a guided relaxation/meditation exercise
and d) a paced breathing exercise [154]. This study involved 100 healthy
individuals, and 45% of participants showed the greatest response in
HRV to classical music, 36% to white noise, 13% to a guided relaxa-
tion/meditation exercise and 6% to a paced breathing exercise. Inter-
estingly, there was little correlation between the activity eliciting the
largest change in HRV and self-reported well-being following the task
[154]. While this review did not compare different forms of mindfulness
practices, it did compare different attention activities, some of which
include aspects of mindfulness (such as paying attention to breathing).
Indeed, meditation can be seen as an attentional activity, and visa versa.
The finding that individual variations in HRV exist in response to single
exposures to various attention activities, suggest that it is possible that
individuals will respond uniquely to different types of mindfulness
practices.
Consistent with this conclusion is a more recent study that compared
partiality towards meditation practices, based on anchors from different
sensory modalities, in 82 healthy individuals. Individuals reported that
their motivation to engage in meditation practices differed based on the
attentional anchor (breath vs image vs mantra). Interestingly, the fav-
oured anchor changed at some point for 77% of the participants, after
engaging with each form of meditation. Additionally, over half (56%) of
the participants reported preferring a different anchor by the end of the
study, compared to their initial meditation-naive preference. Moreover,9
the attentional anchor was not found to predict changes in HR and HRV
response. However, it should be noted that the technology used to
monitor cardiac response in this particular study was somewhat unreli-
able [155]. There is limited research exploring the importance of indi-
vidual differences with regard to meditation practices. Therefore, future
research should be conducted to better understand individual response
differences to meditation and how these might impact stress reactivity
and mental health outcomes.
3.5. Strengths and limitations
The strengths of this review are that it is the first to examine the ef-
fects of meditation on physiological, psychological and neurobiological
outcomes collectively, in the context of mood outcomes. Therefore, we
have provided a comprehensive synthesis demonstrating the meditation
impacts multiple processes, however, further research should explore the
potential interaction between these processes as it is possible that effects
may be synergistic rather than in silos. To best capture the current state of
research in this field, studies were not included or excluded based on
quality assessment. Furthermore, this review does not provide an
exhaustive list of all of the psychological, physiological and neurobio-
logical changes associated with meditation, but rather focuses of those
we hypothesis to be particularly relevant for stress regulation. A limita-
tion of the current research is that we have not conducted a quality
assessment of included studies and therefore the methodological rigour
of the discussed studies is unknown. In future research, it would be of
value to include a formal assessment of the quality of reviewed research.
While we included systematic reviews and Meta-Analysis, some of the
included Meta-Analysis [57,146] included primary studies based on
long-term practitioners, and studies that involved a small number of
participants, and therefore the level of evidence provided in these studies
is limited [156] and should be considered as preliminary, indicating a
need for further research into the impact of meditation on structural and
functional brain changes.
4. Discussion and future directions
This narrative literature adds to the existing body of research by
identifying how meditation practices impact stress reactivity from a
psychological, physiological and neurobiological perspective concur-
rently and therefore demonstrates that the positive impacts of meditation
on mood likely result from influencing stress reactivity and stress resil-
ience, via multiple and interacting pathways. Based on the evidence
reviewed, we suggest that meditation-based practices can decrease stress
reactivity, resulting in overall improved health and wellbeing [157].
Meditation practices are shown to influence many psychological pro-
cesses that can influence an individual’s psychological response and
relationship with stressors [158], including self-compassion [159],
rumination [160], exposure [161], metacognition [85] and attention
[46]. Such practices influence physiological markers of stress reactivity,
including changes in blood pressure, heart rate, cortisol or cytokine
levels, in diverse populations of adults [55,88,162,163]. Acute and
chronic stress and subsequent excess corticosteroids can damage the
brain [17], particularly in areas associated with the regulation of mood
and emotion, including the hippocampus [18] and the prefrontal cortex
[19]. On the other hand, meditation practice is associated with structural
and functional changes in brain regions involved in the regulation of
mood, emotion and relevant modifiable psychological processes such as
rumination and meta-cognition. Meditation is associated with changes in
stress-related measures such as cortisol, and possibly some inflammatory
proteins, however, further research is required to determine if these ef-
fects are robust. We speculate that the various psychological, physio-
logical and neurobiological effects discussed in the current study
influence one another in a bi-directional manner.
There are still a number of other outstanding questions that are
relevant for future research. For example, there are potentially important
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the lengths of training and other factors. At present, there are vastly
different amounts of evidence supporting different forms of meditation
for different clinical conditions (e.g., the evidence for MBCT as a
depression relapse prevention strategy is strong [39,164,165], while the
evidence for MBCT as treatment of bipolar disorder is less robust [166]).
Therefore, future research should further examine the difference be-
tween various forms of meditations in different populations to better
understand differences in the impact of various forms of meditation on
mood outcomes in different populations.
It is also possible that meditation practices may be detrimental in
specific circumstances and for some people. For example, case reports
exist of one or a few individuals describing severe symptoms induced by
several forms of meditation (Transcendental, Zen, Mindfulness), often
occurring in the context of intensive retreats. However, these incidents
have not been reported following evidence-based mindfulness in-
terventions [167]. Even in the absence of severe symptoms, meditation
can occasionally result in subjective distress and functional impairment
[168]. This highlights the need for teachers to understand the theoretical
and mechanistic foundations of meditation practices, so that they can
explain why they might be relevant, what difficulties might arise, and
how these can be managed [169].
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